vimarsana.com

Page 4 - மைய மருந்துகள் ஆய்வகம் இல் கச Ul லி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First jab of Sputnik V Covid-19 vaccine administered; to cost around Rs 1,000 | India News

First doses of Sputnik V administered in India. Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy s Laboratories receives the first jab of the vaccine in Hyderabad. (ANI) HYDERABAD: With the Sputnik V Covid-19 vaccine receiving clearance in India, Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy s Laboratories received the first jab of the vaccine in Hyderabad. The first consignment of imported doses of Sputnik V vaccine landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory at Kasauli in Himachal Pradesh on May 13. As per a statement, imported doses of the Sputnik V Covid-19 vaccine are presently priced at Rs 948 (+5 per cent GST) per dose, with the possibility of a lower price point when local supply begins.

Working with regulators to bring one-dose Sputnik Light vaccine: Dr Reddy s Labs

UPDATED: May 15, 2021 01:35 IST File photo of Russian single-dose Sputnik Light coronavirus vaccine (Photo Credits: Russian Direct Investment Fund via Reuters) HIGHLIGHTS Sputnik V will be more affordable once production begins in India: Deepak Sapra DRDO s 2-DG drug for Covid patients will be much cheaper than alternatives, Sapra says Russian-made Sputnik V coronavirus vaccine will only be available at select private hospitals, said Deepak Sapra, CEO (API and Services), Dr Reddy s Laboratories. The Hyderabad-based pharma giant has partnered with the Russian Direct Investment Fund (RDIF) to bring the adenoviral-based, two-dose vaccine to India. In the first few days, Sputnik V will only be made available at select private hospitals in the country since the jab needs to be stored at -18 degrees Celsius.

Boost for India s COVID fight as Sputnik V vaccine ready for rollout, will be available in private a- The New Indian Express

Express News Service NEW DELHI: Russia’s Covid-19 vaccine Sputnik V will be available at both government and private facilities within the next few days, TNIE has learnt. This could boost India’s Covid-19 vaccination drive, which has failed to gather pace due to an acute shortage of Covishield and Covaxin.  Hyderabad-based Dr Reddy’s Labs, which conducted Sputnik V’s clinical trials, has the rights to supply 12.5 crore doses of the vaccine. The firm received the first lot of 1.5 lakh doses on May 1. “The rollout of the consignment will be subject to the necessary clearances, which will be processed over the next few days,” Deepak Sapra, CEO (API and services) at Dr Reddy’s told TNIE.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.